Here you’ll find a host of downloadable tools and practical resources to help you improve care for your patients with hidradenitis suppurativa (HS). From symptom checklists and referral templates to comprehensive guides and practical self-management tips, these materials are designed to support you and your patients through every step of the HS journey.
Developed with input from HS experts, this guide provides practical information to help you successfully recognize, manage and communicate with patients
Can you spot the signs and symptoms of HS? Take a look at our algorithm that aims to aid a diagnosis of HS
The symptoms of HS go beyond skin deep. For the true burden of HS and to facilitate holistic care, see the full list of symptoms that patients may experience
This infographic outlines the six proposed stages of HS pathogenesis and highlights the immune cells involved in the progression of HS
This template is intended for general practitioners looking to refer patients with suspected or severe HS to dermatologists in secondary care
Intended for general practitioners who are referring patients with HS to dermatologists when mild-to-moderate HS has not responded to first-line treatment
Here, patients can find everything they need to know about HS, from common triggers and management options to the types of specialists involved in HS care
Help your patients separate fact from fiction with this myth-busting guide to what HS really is and isn't
Many people with HS encounter a variety of medical experts from different specialties. Introduce your patients to the people they may meet along the way
As HS is unique to every patient, their conversation should be too. Prompt your patients to download/print out this guide to take to future appointments
From practical tips to strategies that help support your patients' emotional well-being, find out how you can help your patients make positive changes
*These materials have been co-created and endorsed by people living with HS, who are members of HS patient advocacy groups (PAGs) and patient groups across different European countries.
EU-DA-2400278
Date of preparation: June 2024
